Disease Domain | Count |
---|---|
Infectious Diseases | 9 |
Neoplasms | 5 |
Top 5 Drug Type | Count |
---|---|
Prophylactic vaccine | 6 |
Vaccine | 3 |
Live attenuated vaccine | 3 |
Therapeutic vaccine | 3 |
Recombinant vector vaccine | 3 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. EU [+3] |
First Approval Date31 Jul 2013 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. AU |
First Approval Date09 Sep 2003 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date20 Oct 1997 |
Start Date12 Dec 2024 |
Sponsor / Collaborator |
Start Date16 Oct 2024 |
Sponsor / Collaborator Bavarian Nordic A/S [+1] |
Start Date30 Aug 2023 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Typhoid vaccine live Ty21a(Berna Biotech AG) | Typhoid Fever More | Approved |
Rabies vaccine(Novartis) | Rabies More | Approved |
Smallpox vaccine(Bavarian Nordic A/S) | Monkeypox More | Approved |
Cholera Vaccine Live Oral(Emergent Travel Health) | Dysentery More | Approved |
PXVX-0317 | Chikungunya Fever More | NDA/BLA |